SOTYKTU (deucravacitinib) is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). It is not known if SOTYKTU is safe and effective in children under 18 years of age.
SAFETY AND SIDE EFFECTS
COMMON SIDE EFFECTS THAT MAY OCCUR
It's important to be aware of any side effects that may occur when starting a new treatment.
The most common side effects of SOTYKTU include:
Common cold, sore throat, and sinus infection (upper respiratory infections)
Cold sores (herpes simplex)
Sore on inner lips, gums, tongue, or roof of the mouth (canker sores)
Inflamed hair pores (folliculitis)
These are not all of the possible side effects of SOTYKTU.
Please see full Prescribing Information and Medication Guide for information on all of the side effects reported in clinical studies with SOTYKTU. If you experience any side effects while taking SOTYKTU, be sure to contact your dermatologist.
SAVINGS AND SUPPORT FOR YOU
Once you are prescribed SOTYKTU, there’s a variety of different ways we can help get you started and support you throughout your treatment path.